Transcript Slide 1

Managing Medications in
Clinically Complex Elders
Michael A. Steinman, MD, Joseph T. Hanlon, PharmD, MS
JAMA, Oct 13, 2010, Vol 304, No 14
Payal Patel
Mercer University, Doctor of Pharmacy Candidate 2012
RTR Medical Group
Patient Case

Mr L. is an 84 year old male with dementia who presents to the
clinic with initial concerns of forgetfulness, difficulty walking, and
falling

PMH


Medications


Glyburide, digoxin, warfarin, etodolac, docusate sodium, multivitamin, iron,
memantine, metoprolol, gabapentin, essential fatty acids, acetaminophen
prn, lactulose
Family Hx


atrial fibrillation, diabetes mellitus, hypertension, hyperlipidemia, CKD,
gastritis, GERD
Unable to obtain
Social Hx

Retired writer, plays tennis, lives with his wife
Presentation

Vitals



BP: 135/60
HR: 50s
CrCl: 42 ml/min

MMSE: 13/29

A1C: 5.9%
Multiple Medication Use

About 20% of elderly who live in the community age 65
years and older take 10 or more medications

Greater use of inappropriate medications

Adherence problems

Increased frequency of adverse events

Adverse drug events affect 5 – 35% of elderly patients living in
the community per year

Adverse health outcomes

Cost burden
Introduction

This article summarizes evidence-based
literature regarding improving medication use
and describes a systematic approach for how
healthcare professionals can improve
medication regimens for the benefit of the
patients
Information Gathering

Assessing current medication use




Communication gaps are responsible for 37% of
remediable adverse drug events
Discrepancy between patients’ understanding of what
they should be taking, what they are taking and what
is in physicians record
Little direct evidence as to which method is best for
medication review
Brown bag review can be useful

Review meds, how the patient takes it, assess efficacy
Information Gathering

Assessing adherence





Approximately one-half of older patients have adherence
problems to at least 1 medication
Patients often do not admit to nonadherence
Observe medication organization, pill count and refill history
Address reasons underlying adherence ex: cost, difficulty
opening bottles, etc.
Contact pharmacists regarding concerns about patient
adherence
Information Gathering

Assess patients’ goals of medication use



Medications that increase longevity vs negative
effect on QOL
Assess what the patient and family want to
achieve
Prioritize values
Structured medication management

6 studies performed to assess the efficacy of medication
management

Overall, these programs reduce medication burden,
prevented underuse/overuse of medications

In a large study, medication management reduced the rate
of serious adverse drug events from 0.6 to 0.4 events/1000
person-days (p=0.02)

Less evidence of its effect on clinical outcomes such as
QOL, major clinical events and utilizing health services
Changing the medication regimen

However, it is recommended to structurally manage
medications

Match medications to conditions

Identify overused, underused or misused drugs

Make improvements by changing the dose, frequency
or substituting another drug with a better side effect
profile
Discontinuation of unnecessary
medications

Studies of community based older patients have
shown that they have an average of 1
unnecessary medication on their regimen

A large study found that 44% of older patients
were discharged with at least 1 unnecessary
medication

Drugs that should be avoided in older patients
are used in approximately 20 to 30% of adults
age 65 years and older
Discontinuation of Medications

Look for drugs that lack clear indications and
consider discontinuing them

Screen for drugs that may be harmful in the elderly

Look for drugs that provide limited benefit

Drugs that cause troublesome symptoms / adverse
effects

Decisions of stopping medications should be based
on case and common sense
Discontinuation of Medications

Limited evidence about the best way to stop medications

In one of the studies, 26% drug discontinuations lead to
worsening of underlying disease and 4% lead to withdrawal
reactions

Use a stepwise approach in discontinuing medications

It is important to slowly taper the drugs

Educate patients and monitor patients for adverse
withdrawal events
Underuse of Beneficial Medications

Patients are often not prescribed potentially
beneficial medications

Symptoms such as pain and depression
should be treated

Primary prevention if appropriate

Vitamin D repletion in deficient patients can
prevent falls and risk of fractures
Improving adherence

Randomized controlled trials of strategies to improve compliance
have shown mixed results

Most data suggests that oral counseling or written instructions are
often insufficient

A more useful approach is simplifying medication dosing schedules

Clinicians should prescribe longer acting mediations or combination
drugs when possible to decrease frequency

Behavioral interventions – medication organizers, packaging, cues

Lower cost generics can also help patients with financial problems
Monitoring and Follow-up

Ongoing monitoring for drug toxicity and efficacy is
important in providing patient care

Approximately 1/3rd -2/3rd patients receiving digoxin,
carbamazepine and other drugs that need monitoring
are not monitored regularly

Patient’s medication list should be reviewed regularly

Medication review should also be done when there is
sudden decline in function or onset or worsening of
certain syndromes
Conclusion

Managing medications for older patients is a
complex task

A careful, step-wise approach should be
taken to reduce the complexity and to help
the patient achieve beneficial outcomes
Patient Case - Assessment/Plan

Patient no longer had pain from his lumbar laminectomy

Tapering off etodolac and gabapentin while watching for increased reports of
pain

Tapering off digoxin watching for his heart rate

Hemoglobin 13 g/dL

Discontinue iron

Recommend yoga and gym twice weekly

Low serum 1,25-dihydroxyvitamin D level


Added Vitamin D 800 IU/day to Mr L’s regimen
Dr. S asked Mrs L if memantine was helping Mr L’s memory and she
wasn’t sure

Dr. S tapered off memantine and Mr. L had diffculty with nouns and names so
he resumed memantine
Outcomes

Mr. L is now socially improved and feeling
better

His activities of daily living have been stable